Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · October 29, 2024

Efficacy and Safety of Treatment With Omalizumab in Patients With Bullous Pemphigoid

Clinical and Experimental Dermatology

 

Additional Info

Clinical and Experimental Dermatology
Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience
Clin Exp Dermatol 2024 Aug 22;49(9)1002-1006, Á Aguado Vázquez, A Estébanez Corrales, FJ Melgosa Ramos, JM Mascaró Galy, J Fulgencio-Barbarin, X Bosch Amate, L Curto Barredo, M Blanes-Martínez, R Ruiz-Villaverde, A Ballester Martínez, D Martín-Torregrosa, JL Castaño Fernández, R Cabeza Martínez, A Pérez-Ferriols, D Ramos Rodríguez, J Boix Vilanova, G Melé-Ninot, V Expósito Serrano, A España Alonso, A Mateu-Puchades

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading